Cowealth Medical China Co.,Ltd. (SHA:603122)
China
· Delayed Price · Currency is CNY 15.25
-0.30 (-1.93%)
At close: Apr 29, 2026
Cowealth Medical China Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 6,070 | 9,712 | 2,790 | 3,204 | 4,458 | - | Upgrade
|
| Market Cap Growth | 114.49% | 248.07% | -12.92% | -28.13% | - | - | Upgrade
|
| Enterprise Value | 6,051 | 9,547 | 2,712 | 3,076 | 4,347 | - | Upgrade
|
| Last Close Price | 15.25 | 24.40 | 6.88 | 7.81 | 10.67 | - | Upgrade
|
| PE Ratio | - | - | 101.22 | 67.91 | 53.90 | - | Upgrade
|
| PS Ratio | 9.25 | 14.33 | 2.97 | 2.93 | 3.48 | - | Upgrade
|
| PB Ratio | 5.80 | 9.17 | 2.38 | 2.74 | 3.78 | - | Upgrade
|
| P/TBV Ratio | 5.85 | 9.24 | 2.40 | 2.77 | 3.79 | - | Upgrade
|
| P/FCF Ratio | - | 2795.48 | 27.65 | - | - | - | Upgrade
|
| P/OCF Ratio | - | 549.35 | 21.02 | 284.04 | - | - | Upgrade
|
| EV/Sales Ratio | 9.22 | 14.09 | 2.89 | 2.82 | 3.40 | - | Upgrade
|
| EV/EBITDA Ratio | - | - | 64.32 | 42.93 | 40.66 | - | Upgrade
|
| EV/EBIT Ratio | - | - | 77.34 | 47.71 | 43.97 | - | Upgrade
|
| EV/FCF Ratio | -66.51 | 2747.99 | 26.87 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.06 | 0.04 | 0.06 | 0.07 | 0.17 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 1.15 | 0.94 | 0.73 | 1.13 | Upgrade
|
| Debt / FCF Ratio | - | 17.64 | 0.50 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.02 | -0.08 | -0.18 | -0.11 | -0.22 | -0.02 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.65 | 2.61 | -4.99 | -1.77 | -2.40 | -0.14 | Upgrade
|
| Net Debt / FCF Ratio | 0.23 | -25.37 | -2.08 | 2.24 | 4.56 | 1.03 | Upgrade
|
| Asset Turnover | 0.44 | 0.46 | 0.64 | 0.72 | 0.96 | 1.07 | Upgrade
|
| Inventory Turnover | 3.01 | 3.11 | 3.83 | 4.33 | 5.34 | 5.91 | Upgrade
|
| Quick Ratio | 2.31 | 2.36 | 3.17 | 3.38 | 3.01 | 2.36 | Upgrade
|
| Current Ratio | 3.05 | 3.06 | 4.05 | 4.39 | 3.90 | 3.22 | Upgrade
|
| Return on Equity (ROE) | -3.23% | -3.02% | 2.43% | 4.02% | 8.38% | 10.60% | Upgrade
|
| Return on Assets (ROA) | -1.68% | -1.77% | 1.48% | 2.67% | 4.61% | 5.75% | Upgrade
|
| Return on Invested Capital (ROIC) | -3.98% | -4.27% | 2.52% | 4.71% | 8.44% | 10.94% | Upgrade
|
| Return on Capital Employed (ROCE) | -3.80% | -3.90% | 3.00% | 5.50% | 8.30% | 12.50% | Upgrade
|
| Earnings Yield | -0.59% | -0.35% | 0.99% | 1.47% | 1.85% | - | Upgrade
|
| FCF Yield | -1.50% | 0.04% | 3.62% | -1.77% | -1.26% | - | Upgrade
|
| Dividend Yield | 0.84% | - | 1.89% | 0.77% | 1.41% | - | Upgrade
|
| Payout Ratio | - | - | 97.75% | 138.28% | 90.11% | 99.28% | Upgrade
|
| Buyback Yield / Dilution | -18.29% | -6.79% | -0.15% | -4.58% | -26.53% | 1.71% | Upgrade
|
| Total Shareholder Return | -17.45% | -6.79% | 1.74% | -3.81% | -25.13% | 1.71% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.